Bristol Myers Squibb stock trades pre-market at EUR 53.29
Published on 10/19/2026 at 07:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and morning price
- Bristol Myers Squibb develops medicines across oncology, hematology, neuroscience, immunology and cardiovascular medicine.
- The home market is the S&P 500 in the United States.
- Bristol Myers Squibb stock trades pre-market at EUR 53.29 at 7:41 a.m. CEST at Lang & Schwarz on October 19, 2026.
Bristol Myers Squibb develops medicines across oncology, hematology, neuroscience, immunology and cardiovascular medicine, according to the company's investor materials. Bristol Myers Squibb stock was at EUR 53.29 pre-market at 7:41 a.m. CEST at Lang & Schwarz on October 19, 2026.
Before the Xetra open
The price indication came from Lang & Schwarz during the pre-market phase. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.
The group and its market
Bristol Myers Squibb develops pharmaceutical products for patients in its listed therapeutic areas. Its investor page provides sections for financial reporting, events and presentations, press releases and the company's pipeline. The stock's home market is the United States. Market context: Market report S&P 500.
